Lander Willem - Infectious Diseases

Author Information

Lander Willem is a researcher affiliated with the Centre for Health Economics Research & Modeling Infectious Diseases at the Vaccine and Infectious Disease Institute, University of Antwerp, located in Antwerp, Belgium. His work primarily revolves around infectious diseases, with a strong focus on modeling and economic evaluation of vaccination strategies.

Research Contributions

Lander Willem has made significant contributions to the field of infectious diseases, particularly in the context of the COVID-19 pandemic. His research includes studies on COVID-19 mortality and infection fatality ratio in Belgium, the impact of superspreading events on disease outcomes, and the role of risk perceptions in influencing contact frequency during the pandemic. He has also explored the cost-effectiveness of respiratory syncytial virus prevention strategies and evaluated workplace influenza vaccination programs. His work often employs modeling techniques to assess the implications of human mixing patterns on infectious disease transmission.

Aliases

Lander Willem is also recognized by the aliases L Willem and L. Willem.

Publication and Citation Metrics

Metric	Value
Total Citation Count	1600
H-index	23
Total Number of Papers	80

Publications:

COVID-19 mortality, excess mortality, deaths per million and infection fatality ratio, Belgium, 9 March 2020 to 28 June 2020

DOI: 10.2807/1560-7917.ES.2022.27.7.2002060

Year: 2022

Different forms of superspreading lead to different outcomes: heterogeneity in infectiousness and contact behavior relevant for the case of SARS-CoV-2

DOI: 10.1101/2022.03.03.22271824

Year: 2022

The in uence of risk perceptions on close contact frequency during the SARS-CoV-2 pandemic

DOI:

Year: 2022

The influence of risk perceptions on close contact frequency during the SARS-CoV-2 pandemic

DOI: 10.1038/s41598-022-09037-8

Year: 2022

Exploring the Pareto front of multi-objective COVID-19 mitigation policies using reinforcement learning

DOI: 10.48550/arXiv.2204.05027

Year: 2022

Inferring age-specific differences in susceptibility to and infectiousness upon SARS-CoV-2 infection based on Belgian social contact data

DOI: 10.1371/journal.pcbi.1009965

Year: 2022

Cost-effectiveness of Respiratory Syncytial Virus Disease Prevention Strategies: Maternal Vaccine Versus Seasonal or Year-Round Monoclonal Antibody Program in Norwegian Children.

DOI: 10.1093/infdis/jiac064

Year: 2022

Exploring human mixing patterns based on time use and social contact data and their implications for infectious disease transmission models

DOI: 10.1101/2022.01.25.22269385

Year: 2022

Economic Evaluation of Vaccines: Belgian Reflections on the Need for a Broader Perspective.

DOI: 10.1016/j.jval.2020.09.005

Year: 2021

Workplace influenza vaccination to reduce employee absenteeism: An economic analysis from the employers' perspective.

DOI: 10.1016/j.vaccine.2021.02.020

Year: 2021

What Can Individuals Do to Help?

What are the symptoms of Plasmodium falciparum malaria?

How Can Infectious Diseases Be Prevented?

Why are drug interactions important in infectious diseases?

What is Veterinary Medicine?

What are the Challenges with ACTs?

What is Chlamydia trachomatis?

What Kind of Data is Collected?

How Can We Prevent Infections?

How Are Fungal Infections Treated?

Partnered Content Networks

Relevant Topics